Facilitated By

San Antonio Medical Foundation

News

  • UT San Antonio to lead $38 million national trial testing drugs to extend healthspan

    The San Antonio Claude D. Pepper Center aims to improve the health and independence of all older adults with a strong focus on our local South Texas ...

  • AnaptysBio Hits New 52-Week High After Analyst Upgrade - San Diego Today

    ... biotech company's stock traded as high as $58.50 during the session ... San Antonio · San Diego · San Francisco · San Jose · Seattle · Tampa · Tucson ...

  • Barclays Raises AnaptysBio Price Target to $79 - San Diego Today

    San Antonio · San Diego · San Francisco · San Jose · Seattle · Tampa · Tucson ... The increased price target from Barclays suggests analysts see strong ...

  • Anbio Biotechnology Prioritizes Profitability Over Sales Volume - Athens Today

    Anbio Biotechnology, a developer of in vitro diagnostics (IVD) ... San Antonio · San Diego · San Francisco · San Jose · Seattle · Tampa · Tucson ...

  • Analysis: Why the Cornyn-Paxton runoff could be a 'nightmare scenario' for Republicans

    “This is a nightmare scenario for Republicans,” said Jon Taylor, a political science professor at the University of Texas at San Antonio. The runoff ...